<SEC-DOCUMENT>9999999995-24-003791-index.html : 20241217
<SEC-HEADER>9999999995-24-003791.hdr.sgml : 20241217
<ACCEPTANCE-DATETIME>20241217001510
ACCESSION NUMBER:		9999999995-24-003791
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241216
DATE AS OF CHANGE:		20241217
EFFECTIVENESS DATE:		20241216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Neurogene Inc.
		CENTRAL INDEX KEY:			0001404644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				980542593
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283561
		FILM NUMBER:		241553497

	BUSINESS ADDRESS:	
		STREET 1:		535 W 24TH STREET
		STREET 2:		5TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10011
		BUSINESS PHONE:		(877) 237-5020

	MAIL ADDRESS:	
		STREET 1:		535 W 24TH STREET
		STREET 2:		5TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Neoleukin Therapeutics, Inc.
		DATE OF NAME CHANGE:	20190812

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AQUINOX PHARMACEUTICALS, INC
		DATE OF NAME CHANGE:	20140128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AQUINOX PHARMACEUTICALS (USA) INC
		DATE OF NAME CHANGE:	20070626
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>